Project Grant R25CA291602
Award Date
7/3/24
Completion Date
6/30/29
Dollars Obligated
$268K
Federal Agency
National Cancer Institute
Federal Grant Program
93.398
Assistance Type
Project Grant
Place of Performance
Chapel Hill, NC 27599, USA
Similar Awards
The National Cancer Institute (NCI) awarded a $240,924 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to the Beckman Research Institute of the City of Hope. The grant, titled "Cancer Aging and Metabolism Research Experience Program (CAMP)," will provide a 10-week summer research experience for 20 undergraduate students focused on cancer, aging, and metabolism research. The program will match students with 30 experienced mentors from the City of Hope across three...
This $312,737 Project Grant award from the National Cancer Institute's Cancer Research Manpower program (CFDA 93.398) aims to establish the Georgia Science Education Initiative NCI YES (GA-YES) program at Emory University. The program will recruit high school students underrepresented in STEM careers from rural and low-socioeconomic status backgrounds in Georgia to participate in a summer mentored cancer research training program focused on cancer disparities. The program will also develop and...
The National Cancer Institute (NCI) awarded a $544,250 Project Grant under the Cancer Treatment Research program (CFDA 93.395) to the University of North Carolina at Chapel Hill (UNC-CH). The grant, effective from July 1, 2024 through June 30, 2029, supports research to address barriers to accurate and timely diagnosis of lymphoproliferative disorders (LPDs) in people living with HIV in Malawi. The key objectives of the project are to: 1) assess causes of diagnostic delays for LPDs in Malawi, 2)...
The University of North Carolina at Chapel Hill (UNC-CH) has been awarded a $2,637,180 Project Grant from the National Cancer Institute (NCI) under the Cancer Research Manpower (CFDA 93.398) federal grant program. This 5-year award, effective July 1, 2024, will support the UNC Medical Scientist Training Program (MSTP), which aims to train an outstanding group of students committed to becoming physician-scientists capable of bridging the gap between science and clinical medicine. The MSTP program...
The National Cancer Institute (NCI) awarded a 5-year, $162,160 Project Grant (CFDA 93.398 - Cancer Research Manpower) to The Ohio State University to improve the assessment of patient-reported outcomes (PROs) among Black/African-American cancer patients. The project aims to: Gain formal training and practical experience in psychometrics, qualitative/mixed methods research, and health disparities research related to cancer care and PROs. Develop a tailored PRO/social determinants of health...
This $477,869 Project Grant awarded by the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) aims to develop tailored, multilevel cervical cancer interventions for ethnically diverse Black women. The primary awardee, the University of Texas at Arlington, will work to (1) identify multilevel determinants of routine cervical cancer screening and follow-up adherence among African American women and Black African immigrant women, (2) co-design intervention components to promote...
This federal Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower program) provides $147,057 to South Carolina State University to investigate the role of calreticulin acetylation on its trafficking to the cell surface in prostate cancer. The research project aims to: 1) investigate trafficking of calreticulin isoforms in prostate cancer cells, 2) understand the mechanisms and partners involved in calreticulin trafficking, and 3) identify the expression...
The National Cancer Institute (NCI) awarded a $342,569 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to the University of North Carolina at Charlotte (UNC Charlotte). The grant, effective March 1, 2025 through February 28, 2030, will fund research to elucidate the regulatory mechanisms of the protein APE1 in activating the ATR DNA damage response signaling pathway. Specifically, the project aims to determine how APE1 forms liquid-liquid phase separations in...
The National Cancer Institute awarded a $1,326,910 Cooperative Agreement under the Cancer Centers Support Grants (CFDA 93.397) program to establish the Howard-Johns Hopkins Comprehensive Alliance in Cancer Research, Education, and Equity (H2CAREE) initiative. This five-year project, running from September 2024 to August 2029, aims to advance cancer care and health equity through a partnership between Howard University and the Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center....
This Project Grant award from the National Cancer Institute (NCI), under the federal Cancer Cause and Prevention Research program (CFDA 93.393), will fund a $334,233 research project conducted by the University of South Carolina. The project aims to examine disparities in the use of novel cancer therapies, as well as the impacts of comorbidities and multilevel factors on treatment outcomes and survival trajectories for lung and colon cancer patients, particularly among minority and rural...